Amar Natarajan, PhDEppley InstituteResearch Focus: Development of chemical probes for protein interactions and novel treatments for cancer; chemical library screening |
||
Joyce Solheim, PhDEppley InstituteResearch Focus: Immunology; cancer biology; immunotherapy development |
||
Ashley Wysong, MDDermatologyResearch Focus: Skin cancer treatment and epidemiology |
||
Jingjing Sun, PhDSPharmaceutical ScienceResearch Focus: Development of novel effective gene/drug delivery systems for enhanced cancer therapy |
||
Hamid Band, MD, PhDEppley InstituteResearch Focus: Breast cancer and intracellular trafficking |
||
Angie Rizzino, PhDEppley InstituteResearch Focus: Transcription regulation; stem cells |
||
Prakash Radhakrishnan, PhDEppley InstituteResearch Focus: glycobiology of pancreatic cancer, autocrine and paracrine cell signaling mechanisms, developing new therapeutics for pancreatic cancer |
||
Grinu Mathew, PhDEppley InstituteResearch Focus: Genetic and epigenetic regulation of prostate cancer metastasis |
||
David Oupicky, PhDPharmaceutical SciencesResearch Focus: Design of multifunctional nanoparticles for the treatment of metastatic cancer and inflammatory conditions |
||
Martin Conda-Sheridan, PhDPharmaceutical SciencesResearch Focus: Designing multifunctional biomaterial, and bioactive small molecules for cancer treatment |
||
Jered Garrison, PhDPharmaceutical SciencesResearch Focus: Targeted molecular imaging and radiotherapeutic agent design, development of cancer specific prodrugs and polymer-based drug delivery systems |
||
Larisa Poluektova, MD, PhDPharmacology & Experimental NeuroscienceResearch Focus: HIV-1 Pathogenesis, therapeutics and vaccines, humanized mice for translational research, stem cell transplantation |
||
Kishore Challagundla, PhDBiochemistry and Molecular BiologyResearch Focus: Role of exosomes and non-coding RNAs in developing immune therapy resistance in pediatric cancers |
||
|
||
DJ Murry, PharMDPharmacy PracticeResearch Focus: Incorporation of innovative dosing strategies into Phase I clinical trials, the development and validation of surrogate endpoints in clinical trials, and the use of pharmacokinetics and pharmacogenomics to individualize drug therapy |
||
So-Youn Kim, PhDObstetrics and GynecologyResearch Focus: Development of treatment approaches to protect the fertility of women who undergo chemotherapy regimens |
||
Chi (Kevin) Zhang, MDRadiation OncologyResearch Focus: Development of novel strategies for delivery of therapies to brain tumors |
||
Paul Trippier, PhDPharmaceutical SciencesResearch Focus: Small molecule drug discovery for cancer and neurodegenerative disorders, Developing chemical probes to dissect pathways related to disease |
||
Mohd W. (Wasim) Nasser, PhDBiochemistry & Molecular BiologyResearch Focus: Investigating novel therapeutic targets and developing innovative therapeutic strategies for aggressive cancers, metastasis |
||
Mark A. Carlson, MD, FACSSurgeryResearch Focus: Development of novel large animal models for tumors including breast, pancreatic and rectal |